Navigation Links
Pharma Pricing and Market Access News from HealthEconomics.Com for December 20, 2013
Date:12/20/2013

Ponte Vedra Beach, FL (PRWEB) December 20, 2013

The December 17, 2013 newsletter from HealthEconomics.Com explored whether the growing need for health outcomes studies will lead to increased research and development costs, and potentially strain the already heavily scrutinized drug development budgets. Health Outcomes studies may last 3-6 years and cost as much as $500 million and include between 10,000 and 25,000 patients, according to Forbes.Com’s article by John LaMattina on December 2, 2013. Despite these costs, pharmaceutical outcome studies are in growing demand not just by regulators and payers, but also patients and clinicians, because they provide data on the real value of the medicines as well as more real-world effectiveness data that is not currently addressed by tightly controlled clinical trials.

Another article in the HealthEconomics.Com Newsletter took a look at what healthcare might look like in 2014, based on a recently released publication by the Healthcare Intelligence Network entitled “Healthcare Trends & Forecasts in 2014: Performance Expectations for the Healthcare Industry”. The publication includes a planning tool for executives called the “pyramid of success” utilized to help assess the industry landscape for physicians and hospitals, including the impact of accountable care organizations, medical homes, and other trends. The future for health plans are examined, including the changes in primary care and sector-by-sector impact from the health insurance changes.

Lastly, a White Paper entitled “Counter Brand Revenue Erosion from Generics through Defensive Pricing Strategies” by Cutting Edge Information is examined, in which defensive pharmaceutical pricing strategies are reviewed for use to counter threats from low-priced generic alternatives. The white paper also covers pricing strategies that can be utilized to effectively support future generic competition.

About HealthEconomics.Com (http://www.healtheconomics.com):
A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for life sciences professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by clicking on the following link: Subscribe to HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/topstories/prweb11440323.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. HealthEconomics.Com Launches Live Streaming Educational Series in HE-Xpo®, the Pharma Industry’s Only Online Virtual Community for Health Economics and Outcomes Research
2. Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics
3. Shimadzu’s New Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals Enables Real-time Quantitative Analysis
4. Americas Pharmaceutical Market Forecasts to 2018
5. Industry Shares, Size, Trend, Analysis, and Forecasts to 2018 Report Available Online by Researchmoz.us
6. Savient Receives Approval From Bankruptcy Court To Sell Substantially All Assets To Crealta Pharmaceuticals
7. The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
8. Hart-Scott-Rodino Waiting Period Expires for Shires Acquisition of ViroPharma
9. WavePharma Unveils Proprietary Chitosan-Based Delivery System for Controlled Release of Key Ingredients in Personal Care Products
10. PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022
11. JCB Laboratories Debuts High Tech Monitoring System That Will Further Enhance Patient Safety, Surpass Compounding Pharmacy Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... , May 19, 2016  AdvancedFlow Systems ... Inc. (AGI), based out of Maple ... Biogas Ltd. to its existing portfolio of contract ... agreement. AFS along with its sister companies Surround ... a vertically integrated industrial group that specializes in ...
(Date:5/19/2016)... , May 19, 2016 ... and (OTC PINK: RGBPP) announced today initiation of ... first cord blood based cancer immunotherapeutic product leveraging ... application, Regen described a generation of cord blood ... by gene silencing.  The product in development will ...
(Date:5/18/2016)... ... May 18, 2016 , ... Shimadzu Scientific ... The University of Toledo. This two-day camp will take place annually starting June ... field of pharmaceutical sciences in preparation for a university academic program. , ...
(Date:5/18/2016)... ... May 18, 2016 , ... Every day, ... result of asthma complications.* Costing more than $56 billion in direct costs annually, ... , “For too many, the suffering associated with uncontrolled asthma can be overwhelmingly ...
Breaking Biology Technology:
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
Breaking Biology News(10 mins):